Analytical Data
-
Gene name
MRPL9
- Application
-
Alternative Names
39S ribosomal protein L9; 39S ribosomal protein L9; mitochondrial; L9mt; mitochondrial; Mitochondrial ribosomal protein L9; MRP-L9; MRPL9; RM09_HUMAN
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BYD2
-
Expression Region
60-267aa
-
Molecular Weight
50.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MRPL9, a gene encoding a mitochondrial ribosomal protein, plays a crucial role in the protein synthesis within mitochondria, which is essential for cellular energy production and overall cellular function. Recent studies have highlighted the importance of mitochondrial ribosomes in maintaining mitochondrial integrity and function, especially in the context of various diseases, including neurodegenerative disorders and cancer, where mitochondrial dysfunction is often a hallmark. The reconstitution of MRPL9 as a recombinant protein has garnered attention as it allows for in-depth studies of its structural and functional properties, as well as its interactions with other mitochondrial components. Understanding the role of MRPL9 in mitochondrial protein synthesis could provide insights into the molecular mechanisms underlying mitochondrial-related diseases and may pave the way for the development of targeted therapeutic strategies. Furthermore, recombinant MRPL9 can serve as a valuable tool in deciphering the complex regulatory networks governing mitochondrial biogenesis and function. As such, the study of MRPL9 not only enhances our comprehension of mitochondrial biology but also holds potential implications for advancing therapeutic approaches in human health and disease management.
